TY - JOUR
T1 - FDG-PET/CT is superior to enhanced CT in detecting recurrent subcentimeter lesions in the abdominopelvic cavity in colorectal cancer
AU - Yoon, Hai Jeon
AU - Lee, Jong Jin
AU - Kim, Yu Kyeong
AU - Kim, Sang Eun
N1 - Funding Information:
This research was supported by grant no. 11-2010-022 from the SNUBH Research Fund.
PY - 2011/6
Y1 - 2011/6
N2 - Purpose This study aims to compare the performance of contrast-enhanced computed tomography (CeCT) and 18 Ffluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in detecting small tumor implants and metastatic lymph nodes (LNs) in the abdominopelvic cavity in patients with colorectal cancer. Methods We enrolled 16 patients who were clinically suspected of experiencing a recurrence (6 male, 10 female; mean age 61±14 years). All subjects underwent CeCT and PET/CT, and the performance of these methods was compared with regard to detecting recurrences. The final diagnosis of a recurrence was made clinically. Results CeCT identified 38 lesions in 12 patients, all of which were detected by PET/CT. PET/CT found 27 additional lesions in 8 patients, comprising 9 seeding nodules (2 in the right upper quadrant of the abdomen and 7 in the pelvic cavity) and 18 LNs (2 celiac, 2 paraaortic, 2 hepatic hilar, 11 common iliac, 1 external iliac). Most additional lesions were located in the pelvic cavity (approximately 78% of seeding nodules and 67% of lymph nodes). The maximum standardized uptake value (SUVmax) of the additional seeding nodules that were detected solely by PET/CT was significantly higher compared with the CeCT- and PET/CT-confirmed nodules (5.5±4.2 vs. 2.9±2.5, p=0.03). The seeding nodules that were detected only by PET/CT were significantly smaller than the CeCT- and PET/CT-confirmed nodules (long axis: 1.0±0.3 cm vs. 2.0±1.1 cm, p=0.001; short axis: 0.8± 0.3 cm vs. 1.4±0.8 cm, p=0.004; mean of both axes: 0.9± 0.3 cm vs. 1.7±0.9 cm, p=0.001). Similarly, PET/CT-onlydetected LNs were significantly smaller than CeCT- and PET/CT-identified LNs (0.7±0.1 cm vs. 2.3±1.2 cm, p<0.0001). Conclusion PET/CT is superior to CeCT in detecting seeding nodules and metastatic LNs in patients with recurrent colorectal cancer. Specifically, PET/CT detects subcentimeter lesions in anatomically deformed pelvic cavities.
AB - Purpose This study aims to compare the performance of contrast-enhanced computed tomography (CeCT) and 18 Ffluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in detecting small tumor implants and metastatic lymph nodes (LNs) in the abdominopelvic cavity in patients with colorectal cancer. Methods We enrolled 16 patients who were clinically suspected of experiencing a recurrence (6 male, 10 female; mean age 61±14 years). All subjects underwent CeCT and PET/CT, and the performance of these methods was compared with regard to detecting recurrences. The final diagnosis of a recurrence was made clinically. Results CeCT identified 38 lesions in 12 patients, all of which were detected by PET/CT. PET/CT found 27 additional lesions in 8 patients, comprising 9 seeding nodules (2 in the right upper quadrant of the abdomen and 7 in the pelvic cavity) and 18 LNs (2 celiac, 2 paraaortic, 2 hepatic hilar, 11 common iliac, 1 external iliac). Most additional lesions were located in the pelvic cavity (approximately 78% of seeding nodules and 67% of lymph nodes). The maximum standardized uptake value (SUVmax) of the additional seeding nodules that were detected solely by PET/CT was significantly higher compared with the CeCT- and PET/CT-confirmed nodules (5.5±4.2 vs. 2.9±2.5, p=0.03). The seeding nodules that were detected only by PET/CT were significantly smaller than the CeCT- and PET/CT-confirmed nodules (long axis: 1.0±0.3 cm vs. 2.0±1.1 cm, p=0.001; short axis: 0.8± 0.3 cm vs. 1.4±0.8 cm, p=0.004; mean of both axes: 0.9± 0.3 cm vs. 1.7±0.9 cm, p=0.001). Similarly, PET/CT-onlydetected LNs were significantly smaller than CeCT- and PET/CT-identified LNs (0.7±0.1 cm vs. 2.3±1.2 cm, p<0.0001). Conclusion PET/CT is superior to CeCT in detecting seeding nodules and metastatic LNs in patients with recurrent colorectal cancer. Specifically, PET/CT detects subcentimeter lesions in anatomically deformed pelvic cavities.
KW - Enhanced CT
KW - PET/CT
KW - Recurrent colorectal cancer
KW - Subcentimeter
UR - http://www.scopus.com/inward/record.url?scp=79960070229&partnerID=8YFLogxK
U2 - 10.1007/s13139-011-0082-z
DO - 10.1007/s13139-011-0082-z
M3 - Article
AN - SCOPUS:79960070229
SN - 1869-3474
VL - 45
SP - 132
EP - 138
JO - Nuclear Medicine and Molecular Imaging
JF - Nuclear Medicine and Molecular Imaging
IS - 2
ER -